Diet in the Management of Acromegaly
Launched by CEDARS-SINAI MEDICAL CENTER · May 28, 2022
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a low carbohydrate and low gluten diet might help people with acromegaly, a condition often caused by a growth hormone-producing tumor in the pituitary gland. The study aims to see if this type of diet can slow down the progression of acromegaly, improve symptoms, and enhance treatment outcomes.
To participate, individuals need to be diagnosed with acromegaly and should not have any dietary restrictions that would prevent them from following the study diet. The trial is currently recruiting participants aged 65 to 74, and they welcome people of all genders. If you join the study, you can expect to follow the special diet and have regular check-ups to monitor your health and any changes in your condition. This research could be important for finding new ways to manage acromegaly effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of acromegaly.
- Exclusion Criteria:
- • Diet restrictions.
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials